SBILIFE1,691.00

SBI Life Insurance Company Ltd.

· Banking & Finance
AnnualQuarterly₹ CrorePeersHDFCLIFEICICIPRULILICISHRIRAMFINJIOFINBANKBARODACANBKPNB
View
In ₹ Crore except Per Share
12 Months Ending
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Total Income24,169.438,695.922,809.245,803.05,657.746,090.7
Expenses
Total Expenses22,606.238,227.722,609.145,375.73,463.945,550.8
Profit
+ Current Tax60.045.218.644.451.247.3
Revenue Detail — as filed
+ Investment Income251.1292.9322.3356.3326.0281.6
+ Income from Investments (net)-1,040.821,525.1-2,055.315,531.0-23,938.725,977.0
Expense Detail — as filed
+ Advertisement & Publicity76.043.842.156.695.754.3
+ Employee Remuneration & Welfare681.9709.2827.91,007.8706.9798.6
+ Commission997.8666.01,240.31,610.2859.1929.6
+ Commission (net)776.8786.11,240.31,610.2859.1929.6
+ Provision — Diminution in Investments6.5-12.442.1-0.8-21.1-0.3
+ Provision — Doubtful Debts & Write-offs0.10.30.20.20.30.1
Profit Build-up — Alternate / Pre-Ind-AS Tags
Profit / (Loss) before Tax840.6610.9513.2597.5815.8745.9
+ Current Taxes27.116.618.620.811.120.9
+ Provision for Tax60.045.218.644.451.247.3
+ Provisions for Taxes27.116.618.620.811.120.9
PAT before Extraordinary Items813.5594.4494.6576.7804.6724.9
PAT after Extraordinary Items813.5594.4494.6576.7804.6724.9
Profit Carried to Balance Sheet15,630.616,224.916,719.517,296.217,830.118,555.0
Per Share — as-filed variants
Basic & Diluted EPS before Extraordinary (not annualised)8.125.934.935.758.027.23
Basic & Diluted EPS after Extraordinary (not annualised)8.115.934.935.758.027.22
Appropriations & Transfers
Reserves & Surplus excl. Revaluation Reserve15,790.716,405.016,921.217,523.318,083.118,822.0
+ Interim Dividend0.00.00.00.00.00.0
Insurance — Revenue Account (Policyholders')
+ Gross Premium Income24,001.517,813.925,083.930,449.527,938.921,289.7
+ Net Premium Income23,860.717,178.524,848.330,245.327,683.820,078.2
+ First-year Premium4,858.73,539.55,289.57,919.35,092.74,954.9
+ Renewal Premium14,680.310,546.314,002.817,471.716,714.012,381.8
+ Single Premium4,462.53,728.15,791.65,058.46,132.23,952.9
+ Commission — First-year Premium567.1393.5795.31,085.8416.2612.4
+ Commission — Renewal Premium370.8223.9354.2433.8440.3251.5
+ Commission — Single Premium59.948.790.890.62.665.7
+ Expenses of Management2,015.11,915.22,759.23,519.42,527.42,565.0
+ Operating Expenses — Insurance Business1,238.31,129.11,518.91,909.21,668.31,635.5
+ Expenses — Non-insurance10.47.514.64.92.76.9
+ Benefits Paid (net)12,528.310,118.413,482.114,468.416,254.613,126.7
+ Change in Actuarial Liability7,706.025,899.96,039.227,347.4-15,348.429,811.6
+ Bonus Allocated to Policyholders1,967.20.00.00.02,060.50.0
+ Interim Bonus Paid18.26.48.76.38.46.8
+ Terminal Bonus Paid163.783.5147.9183.2258.9127.6
+ GST on Linked Charges290.2261.1267.7-3.4-0.10.4
Surplus in the Revenue Account1,563.2468.2200.2427.32,193.8539.9
Net Surplus / (Deficit)1,563.2468.2200.2427.32,193.8539.9
+ Funds for Future Appropriation-384.4146.6-5.6158.1-169.882.1
+ Policyholders' Liabilities to Shareholders' Fund0.30.30.30.30.225.1
Insurance — Shareholders' Account
+ Income under Shareholders' Account251.3292.9322.3356.3326.0281.7
+ Shareholders' Account Income2,199.0614.4528.1625.52,689.6739.5
+ Shareholders' Account Expenses1,358.43.514.928.01,873.8-6.3
+ Shareholders' Provision — Diminution in Investments2.1-4.10.223.1-2.8-13.3
+ Transfer from Policyholders' Account1,947.7321.5205.7269.22,363.6457.8
+ Transfer of Funds to Policyholders' Account1,345.90.00.00.01,873.90.0
+ Transferred to Shareholders' Account1,947.7321.5205.7269.22,363.6457.8
Shareholders' Fund — with Unrealised Gains0.00.00.00.0-0.00.2
Shareholders' Fund — without Unrealised Gains0.00.00.00.00.00.1
Insurance — Fund NPAs
+ Linked Non-participating — with Unrealised Gains-0.00.0-0.00.0-0.00.0
+ Linked Non-participating — without Unrealised Gains0.00.00.00.00.00.0
+ Non-linked Participating — with Unrealised Gains0.00.0-0.00.0-0.00.0
+ Non-linked Participating — without Unrealised Gains0.00.00.00.00.00.0
+ Non-linked Non-participating — with Unrealised Gains0.00.0-0.00.0-0.00.0
+ Non-linked Non-participating — without Unrealised Gains0.00.00.00.00.00.0
Insurance — IRDAI Ratios (as filed, not percentages)
Solvency Ratio0.020.020.020.020.021.96
Conservation Ratio0.010.010.010.010.010.88
Expenses of Management Ratio0.000.000.000.000.000.12
Persistency — 13th Month0.010.010.010.010.010.84
Persistency — 25th Month0.010.010.010.010.010.77
Persistency — 37th Month0.010.010.010.010.010.71
Persistency — 49th Month0.010.010.010.010.010.68
Persistency — 61st Month0.010.010.010.010.010.59
Regulatory Disclosures — filed alongside, not part of the P&L
Investor Complaints — Received0.004.005.000.003.007.00
Investor Complaints — Disposed0.004.005.000.003.007.00
Related-party Transactions — During the Period8,176.85,470.87,058.9
Other Filed Concepts — mapped but not yet placed in the schedule
Other Operating Expenses480.5376.2649.0844.8865.7782.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.